Member Societies

• All
• 298
• 299
• 300

Symposium 13 (KSG) : COVID-19 and GI Diseases: How to Manage the Patients English

Date / Time	298,
Channel
Speakers	15:55-16:17	COVID-19 and Endoscopy: Impact and Countermeasures
	16:17-16:39	COVID-19 and IBD
	16:39-17:01	COVID-19 and Cancer

Symposium 06 (KSG) : Clinical Application of Radiomics in Gastroenterology English

Date / Time	298,
Channel
Speakers	12:25-12:47	Radiomics-based clinical model for hepatocellular cancer
	12:47-13:09	Radiomics approaches in gastric cancer and colon cancer
	13:09-13:31	Application of radiomics in inflammatory bowel disease
	13:31-13:53	The application of novel diagnostics and radiomics in the evaluation of pancreatic cystic lesions

Big Data Session 01 (KSG) : Recent Study Using National Health Insurance Research Database in GI Diseases English

Date / Time	298,
Channel
Speakers	15:55-16:17	Chemoprevention of hepatocellular carcinoma: Aspirin and statin
	16:17-16:39	Trends in pancreatitis and pancreatic cancer risk among patients with newly diagnosed type 2 diabetes receiving dipeptidyl peptidase 4 inhibitors
	16:39-17:01	Risk of gastric cancer development: Proton pump inhibitors vs histamine 2 receptor
	17:01-17:23	Severe clinical outcomes of COVID-19 associated with proton pump inhibitors

Symposium 14 (KSG) : Future Diagnosis of Gastrointestinal Disease: Biomarkers and Beyond English

Date / Time	299,
Channel
Speakers	08:30-08:52	An integrative approach to cancer based on precision medicine
	08:52-09:14	Biomarkers in the diagnosis of gastric cancer
	09:14-09:36	Proteomics for PIVKA-II in HCC surveillance
	09:36-09:58	Esophageal impedance test: A new diagnostic approach for GERD and functional esophageal disorder

Symposium 16 (KSG) : The Evolution of Personalized Medicine in Gastroenterology English

Date / Time	299,
Channel
Speakers	10:15-10:37	Tailored therapy for refractory Helicobacter pylori infection
	10:37-10:59	Personalized therapeutic approach to inflammatory bowel disease
	10:59-11:21	State of the art for liquid biomarkers in pancreatic cancer: An important consideration in the era of precision oncology
	11:21-11:43	The emerging role of liquid biopsy in digestive cancer

Big Data Session 02 (KSG) : Using Big Data to Discover Diagnostics and Therapeutics for GI Diseases English

Date / Time	299,
Channel
Speakers	12:25-12:47	Big data research in IBD: From real world data to real world evidence
	12:47-13:09	Deep dive into bioinformatics in gastrointestinal cancer
	13:09-13:31	Development of therapeutic decision model in hepatology using artificial intelligence
	13:31-13:53	Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learning

Basic/Translational Symposium 03 (KSG) : Exploring a New Way Out Using Novel Molecule and Cell Therapy in GI Cancer English

Date / Time	299,
Channel
Speakers	14:10-14:32	Early detection and stratification of gastric cancer through stem cell marker and miRNA
	14:32-14:54	Overcoming peritoneal metastasis of colon cancer with STING-based immunotherapy
	14:54-15:16	Anti-tumor therapy of HCC using CAR T Cells derived from iPS cell
	15:16-15:38	Nano-bio system for the capture of pancreatic cancer cell secreted exosomes

Combined Symposium 04 (KSG+KSGE) : Endoscopy in Functional GI Disorders English

Date / Time	299,
Channel
Speakers	08:30-08:52	The role of endoscopy in achalasia
	08:52-09:14	The role of endoscopy and biopsy in chronic diarrhea with IBS-D
	09:14-09:36	The role of endoscopy in intestinal pseudo-obstruction, adult Hirschsprung's disease
	09:36-09:58	Anti-reflux endoscopic surgery for Gastroesophageal Reflux Disease

Combined Symposium 05 (KSG+KASID) : Immunity and Microbiome in the Gut English

Date / Time	299,
Channel
Speakers	10:15-10:37	The microbiota of early life and developmental immunology
	10:37-10:59	The effect of immunologic factors in IBS
	10:59-11:21	Microbial modulation of inflammation in IBD
	11:21-11:43	Immune response and gut microbiome in colorectal cancer

Symposium 18 (KSG) : Recent Update for Autoimmune Gastrointestinal Diseases English

Date / Time	299,
Channel
Speakers	12:25-12:47	Classification criteria for IgG4-related disease
	12:47-13:09	Second line management of autoimmune hepatitis
	13:09-13:31	Novel immune therapy in IBD
	13:31-13:53	Novel therapy in primary sclerosing cholangitis

Combined Symposium 07 (KSG+KSGC) : Molecular Classification & Actionable Gene Mutations in GI Cancer English

Date / Time	299,
Channel
Speakers	14:10-14:32	Gastric cancer
	14:32-14:54	Colon cancer
	14:54-15:16	Hepatocellular carcinoma
	15:16-15:38	Pancreatic cancer

PG Course 06 (KSG) : Cancer Screening Program for Gastric Cancers and Colorectal Cancers Korean

Date / Time	300,
Channel
Speakers	10:15-10:37	Guidelines for gastric cancer screening
	10:37-10:59	Results from the national cancer screening program for gastric cancers in Korea
	10:59-11:21	Guidelines for colorectal cancer screening
	11:21-11:43	Results from the national cancer screening program for colorectal cancers in Korea (including population-based colonoscopy screening)